Howard R J, Lillis C, Tuck S M
University Department of Obstetrics and Gynaecology, Royal Free Hospital, London.
BMJ. 1993 Jun 26;306(6894):1735-7. doi: 10.1136/bmj.306.6894.1735.
Sickle cell disease is listed in the manufacturers' data sheets in the United Kingdom as a contraindication to the use of most combined contraceptive pills; the result is confused advice on family planning to a group of women who are at substantial risk from both planned and unplanned pregnancy. A study in north London on the use of contraceptives by women with sickle cell disease indicates that the use of combined oral contraceptives is common. Although medical staff usually advised against pregnancy, such advice was almost always ignored. Over half of the women surveyed had some knowledge about antenatal diagnosis. Family planning advice should be an integral part of the care of women with sickle cell disease. In the absence of specific data to the contrary all methods of contraception may be considered, although with appropriate caution.
镰状细胞病在英国制造商的数据表中被列为大多数复方避孕药使用的禁忌证;结果是,对于一群面临计划内和计划外怀孕重大风险的女性,在计划生育方面给出的建议令人困惑。伦敦北部一项关于镰状细胞病女性使用避孕药具的研究表明,复方口服避孕药的使用很普遍。尽管医务人员通常建议避免怀孕,但这种建议几乎总是被忽视。超过一半接受调查的女性对产前诊断有所了解。计划生育建议应该成为镰状细胞病女性护理的一个组成部分。在没有相反具体数据的情况下,所有避孕方法都可以考虑,但要谨慎使用。